VA Nationwide Infusion Pump Equipment

The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 1 awarded a multiple-award Master IDIQ on August 15, 2025, for nationwide infusion pump equipment, with ordering authority through August 14, 2030. The vehicle carries a combined potential value of $63 million and is unrestricted—no set-asides apply.

The scope covers large volume pumps, syringe pumps, patient controlled analgesia pumps, and associated software, with delivery F.O.B. Destination to VA healthcare facilities nationwide. Task orders include hardware, software, technical support, installation, clinical training, and device implementation. All procured equipment must be FDA-approved with wireless infusion library transmission, configurable alarms, and compatibility with Oracle Health's CareAware Platform.

Activity is front-loaded and concentrated. Thirty-four task orders have been awarded since vehicle establishment, with 31 issued in 2025 and 3 in 2026. Combined task-order potential value stands at $51 million, with $50.9 million obligated—essentially 100% of the committed value. Carefusion Solutions, LLC dominates the vehicle with 25 orders totaling $45.3 million in potential value; ICU Medical Sales, Inc. holds 7 orders worth $5.7 million. The remaining two primes (Marathon Medical Corporation and Baxter Healthcare Corporation) each hold one order of $10 thousand. Ordering is heavily concentrated: the top two primes account for over 99% of task-order value.

Customer concentration is also marked. Veterans Integrated Service Network 22 placed 6 orders ($7.7 million), Veterans Integrated Service Network 20 placed 4 orders ($5.2 million), Veterans Integrated Service Network 2 placed 3 orders ($4.4 million), and Veterans Integrated Service Network 4 placed 3 orders ($3.5 million). The top five VISNs represent roughly 59% of all task orders. The remaining 41% are distributed across 11 other VA customer units.

Task-order values range from minimum guarantees of $10 thousand (four primes each received one on the award date with a five-year performance window through August 14, 2030) to individual orders exceeding $5 million. Most awarded orders carry firm fixed pricing and completion dates between February and September 2026, with one outlier extending to September 2027.